FDA Bureaucrats Seek to Restrict Access to Homeopathic Medicines
… And what we can do to STOP THEM.
Summary: Guidelines now being proposed by the FDA would restrict the public’s access to Homeopathic remedies, benefitting BIG PHARMA, but harming Americans who should continue to have unregulated access to these healing products. Federal law does not give the FDA the authority to apply the rules designed only for toxic pharmaceuticals to nontoxic Homeopathic remedies. The FDA’s only job is to ensure that products are manufactured according to legal standards and are properly labeled. The rules and regulations governing Homeopathic remedies that have been in place for most of the last century are more than adequate to protect the public.
Late last year, the FDA proposed new guidelines for Drug Products Labeled as Homeopathic (Draft Guidance Dec. 2017), disregarding federal law and usurping the right of American people to use historically available health-enhancing products of their choosing. Rather than promote the public welfare, these guidelines, if implemented, will injure countless individuals and the nation’s health. At the end of this article, I delineate the specific threats posed by these proposed guidelines and explain how greater regulation would place unnecessary restrictions on safe and beneficial Homeopathic products. Lastly, I explain how to file comments on-line with the FDA, where comments are due by March 20, 2018.